HCAT Key Statistics, Chart & Performance
The current stock price of HCAT is 2.25 USD. In the past month the price decreased by -4.26%. In the past year, price decreased by -61.01%.
HCAT Technical Analysis
HCAT Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to HCAT. HCAT may be in some trouble as it scores bad on both profitability and health.
HCAT Financial Highlights
Over the last trailing twelve months HCAT reported a non-GAAP Earnings per Share(EPS) of 0.15. The EPS decreased by -42.31% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -18.33% | ||
| ROE | -32.42% | ||
| Debt/Equity | 0.46 |
HCAT Forecast & Estimates
17 analysts have analysed HCAT and the average price target is 3.95 USD. This implies a price increase of 75.67% is expected in the next year compared to the current price of 2.25.
For the next year, analysts expect an EPS growth of -26.69% and a revenue growth 1.28% for HCAT
HCAT Ownership
About HCAT
Company Profile
Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. The company is headquartered in South Jordan, Utah. The company went IPO on 2019-07-25. The firm's solution comprises its cloud-based data platform, applications, and expertise. Its segments include Technology and Professional Services. The Technology segment includes its data platform, analytics applications and support services and earns primarily from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees. The Professional Services segment is generally a combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver capabilities to its clients to fully configure and utilize the benefits of its technology offerings. Its clients, which are primarily healthcare providers, use its Solution to manage their data, derive analytical insights to operate their organization, and produce measurable clinical, financial, and operational improvements.
Company Info
HEALTH CATALYST INC
10897 South River Front Parkway, #300
South Jordan UTAH 84121 US
CEO: Daniel Burton
Employees: 0
Phone: 18017086800
HEALTH CATALYST INC / HCAT FAQ
What does HCAT do?
Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. The company is headquartered in South Jordan, Utah. The company went IPO on 2019-07-25. The firm's solution comprises its cloud-based data platform, applications, and expertise. Its segments include Technology and Professional Services. The Technology segment includes its data platform, analytics applications and support services and earns primarily from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees. The Professional Services segment is generally a combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver capabilities to its clients to fully configure and utilize the benefits of its technology offerings. Its clients, which are primarily healthcare providers, use its Solution to manage their data, derive analytical insights to operate their organization, and produce measurable clinical, financial, and operational improvements.
Can you provide the latest stock price for HEALTH CATALYST INC?
The current stock price of HCAT is 2.25 USD. The price decreased by -4.66% in the last trading session.
What is the dividend status of HEALTH CATALYST INC?
HCAT does not pay a dividend.
What is the ChartMill rating of HEALTH CATALYST INC stock?
HCAT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Where is HEALTH CATALYST INC (HCAT) stock traded?
HCAT stock is listed on the Nasdaq exchange.
Would investing in HEALTH CATALYST INC be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on HCAT.
What is the Short Interest ratio of HEALTH CATALYST INC (HCAT) stock?
The outstanding short interest for HEALTH CATALYST INC (HCAT) is 7.48% of its float.